An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals
Jason Liebowitz, MD, FACR
Jason Liebowitz, MD, FACR, an assistant professor of medicine at Columbia University Vagelos College of Physicians and Surgeons. He completed undergraduate studies at Johns Hopkins University, Baltimore, where he was inducted into Phi Beta Kappa. He attended medical school at Johns Hopkins School of Medicine and completed his Internal Medicine residency at Johns Hopkins Bayview Medical Center, where he served as chief resident. He completed his rheumatology fellowship at Johns Hopkins Hospital and was honored with the 2019 Distinguished Fellow Award from the American College of Rheumatology. His research and writings have been published in The New England Journal of Medicine, JAMA, JAMA Internal Medicine, Arthritis Care and Research and The Journal of Graduate Medical Education, among other journals. He participated in fellowships with the American Federation for Aging Research (Medical Student Training in Aging Research), the American Austrian Foundation (Max Kade Clinical Clerkship in Vienna, Austria), and the fellowships at Auschwitz for the Study of Professional Ethics (through Yale School of Medicine). He is a co-editor of the textbook Clinical Innovation in Rheumatology: Past, Present, and Future, a co-editor of the book Masterclass in Medicine: Lessons from the Experts, and a co-editor of the textbook series Interdisciplinary Rheumatology.
Experts provided an in-depth review of Janus kinase (JAK) inhibitors, discussing the latest research on their use in the treatment of specific rheumatic conditions, the risks associated with them and more.
Matteo Piga, MD, highlighted the latest research into Behçet’s disease, including developments into the understanding of its pathophysiology and positive results for potential treatments.
Janus kinase (JAK) inhibitors, biologics and more—Dr. Laura Coates discussed the management of PsA, providing insights into the current research and when clinicians may want to consider prescribing specific medications.
Experts discussed how aspects of the immune system other than B cells play a role in lupus, including mitochondria in red blood cells, proteins present in urine and more.
The EULAR/ACR/APLAR Research Exchange Program is an opportunity to learn and exchange ideas within the rheumatology community internationally. Here the program’s most recent participants share their experiences & excitement.
Virtual reality technology may be a unique and immersive avenue for educating patients on rheumatic conditions and their treatments, with the potential to enable more informed decision making and improve care.
Pulmonary hypertension and Raynaud’s phenomenon are just some of the symptoms patients with systemic sclerosis (SSc) may experience. Here are insights into the diagnosis and management of SSc.
Lisa Christopher-Stine, MD, MPH, discussed the latest findings on myositis and its subtypes, including insights into antibodies linked to cancer and treatments for these patients.
Jun Kang, MD, addressed the intersection of dermatology and rheumatology, describing the nuance necessary to accurately evaluate skin manifestations and differentiate multiple conditions.